0001438133-21-000226.txt : 20211201
0001438133-21-000226.hdr.sgml : 20211201
20211201195913
ACCESSION NUMBER: 0001438133-21-000226
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211129
FILED AS OF DATE: 20211201
DATE AS OF CHANGE: 20211201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Leal James
CENTRAL INDEX KEY: 0001866570
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36189
FILM NUMBER: 211464539
MAIL ADDRESS:
STREET 1: C/O TANDEM DIABETES CARE, INC.
STREET 2: 11075 ROSELLE STREET
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TANDEM DIABETES CARE INC
CENTRAL INDEX KEY: 0001438133
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204327508
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11075 ROSELLE STREET
CITY: San Diego
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-366-6900
MAIL ADDRESS:
STREET 1: 11075 ROSELLE STREET
CITY: San Diego
STATE: CA
ZIP: 92121
4
1
wf-form4_163840673830554.xml
FORM 4
X0306
4
2021-11-29
0
0001438133
TANDEM DIABETES CARE INC
TNDM
0001866570
Leal James
C/O TANDEM DIABETES CARE, INC.
11075 ROSELLE STREET
SAN DIEGO
CA
92121
0
1
0
0
SVP, Operations
Common Stock
2021-11-29
4
M
0
310
0
A
4162
D
Common Stock
2021-11-29
4
F
0
154
129.66
D
4008
D
Common Stock
2021-11-29
4
M
0
1667
51.50
A
5675
D
Common Stock
2021-11-29
4
M
0
238
82.34
A
5913
D
Common Stock
2021-11-29
4
S
0
1236
130.64
D
4677
D
Common Stock
2021-11-29
4
S
0
664
131.54
D
4013
D
Common Stock
2021-11-29
4
S
0
5
132.92
D
4008
D
Restricted Stock Unit
2021-11-29
4
M
0
310
0
A
Common Stock
310.0
3097
D
Stock Option
51.5
2021-11-29
4
M
0
1667
51.50
A
Common Stock
1667.0
25000
D
Stock Option
82.34
2021-11-29
4
M
0
238
82.34
A
Common Stock
238.0
7148
D
Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
Represents shares of common stock received upon exercise of a stock option award.
The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2020.
The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $130.19 to $131.00. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $131.48 to $132.24.The Reporting Person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).
Each RSU represents a contingent right to receive one share of common stock of the Company.
RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.
The options vested as to twenty-five (25%) of the underlying shares on 2/15/2020, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of the 2013 Plan.
The expiration date for these options is 10 years from the date of grant.
The options vested as to twenty-five (25%) of the underlying shares on 5/27/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the 2013 Plan.
s/ David B. Berger, Attorney-in-Fact for James A. Leal
2021-12-01